MedTrace Logo

Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma

NCT00006565 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2016-02-18

No results posted yet for this study

Summary

The purpose of this study is to test the effects of reducing indoor environmental tobacco smoke (ETS) on unscheduled asthma visits, asthma symptoms, airway inflammation, and exposure to tobacco smoke measured using air nicotine dosimeters, serum and hair cotinine.

Conditions

Interventions

DEVICE

HEPA Air Cleaner

Placement of two active HEPA air cleaners in the homes of children

DEVICE

Placebo Filtration Unit

Placement of inactive filtration unit in the homes

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Bruce P Lanphear, MD, MPH · Simon Fraser University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Primary Completion
2003-03-31
Completion
2004-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006565 on ClinicalTrials.gov